Business

Cryo-Cell International Receives FACT Re-accreditation, Setting the Longest Independently Validated Quality Track Record Among U.S. Private Cord Blood Banks

OLDSMAR, Fla., April 28, 2026--Cryo-Cell International, Inc. (NYSE American LLC: CCEL) (the "Company"), the world’s first private cord blood bank, has been granted renewed Foundation for the Accreditation of Cellular Therapy ("FACT") Accreditation for Cord Blood Collection, Banking, and Release for Administration (Related and Unrelated) Donations. Originally accredited in 2014, the Company’s latest FACT re-accreditation extends for three more years, with the latest renewal effective through Apri

articleCryo-cell International, Inc.April 28, 20263/company/cryo-cell-international-inc/news/cryo-cell-international-receives-fact-re-accreditation-setting-the-longest-independently-validated-quality-track-record-among-us-private-cord-blood-banks
Cryo-Cell International Receives FACT Re-accreditation, Setting the Longest Independently Validated Quality Track Record Among U.S. Private Cord Blood Banks

About this update from Cryo-cell International, Inc.

[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":1024,"height":512,"url":"https://media.zenfs.com/en/business-wire.com/e1894cb11e4c2f1d0049db7e5de091b7"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/6pNYQ3k27.v8V0VwzEtFRw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTQ4MA--/https://media.zenfs.com/en/business-wire.com/e1894cb11e4c2f1d0049db7e5de091b7","width":960,"height":480},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/XzEHHeDDi3xkFb1ykTRGpQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTIwNDg7aD0xMDI0/https://media.zenfs.com/en/business-wire.com/e1894cb11e4c2f1d0049db7e5de091b7","width":1024,"height":512}},"lazy":false},{"type":"text","content":"OLDSMAR, Fla., April 28, 2026--(BUSINESS WIRE)--Cryo-Cell International, Inc. (NYSE American LLC: CCEL) (the "Company"), the world’s first private cord blood bank, has been granted renewed Foundation for the Accreditation of Cellular Therapy ("FACT") Accreditation for Cord Blood Collection, Banking, and Release for Administration (Related and Unrelated) Donations. Originally accredited in 2014, the Company’s latest FACT re-accreditation extends for three more years, with the latest renewal effective through April 3, 2029.","length":547,"tagName":"p"},{"type":"text","content":"The FACT accreditation was issued after Cryo-Cell International, Inc. demonstrated compliance with the NetCord-FACT Standards for Cord Blood Banking — the most rigorous internationally recognized quality framework in cellular therapy.","length":234,"tagName":"p"},{"type":"text","content":"Accreditation Scope and Verification","length":36,"tagName":"p"},{"type":"text","content":"The FACT certificate confirms that Cryo-Cell International, Inc., having met the NetCord-FACT Standards for Cord Blood Banking, is granted FACT Accreditation for Cord Blood Collection, Banking, and Release for Administration (Related and Unrelated) Donations.","length":259,"tagName":"p"},{"type":"text","content":"To verify the official FACT accreditation and other licenses, visit:","length":68,"tagName":"p"},{"type":"text","content":"https://www.cryo-cell.com/healthcare-providers/accreditations-licenses","length":70,"tagName":"p"},{"type":"text","content":"Why FACT Accreditation Matters","length":30,"tagName":"p"},{"type":"text","content":"FACT is an ind...

More updates from Cryo-cell International, Inc.

Cryo-Cell International, Inc.cord blood bankCord Bloodthe CompanyAccreditation